Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Recruiting now · Phase 1/Phase 2
Conditions studied: Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell Carcinoma
In brief
This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced tumors
Key facts
- Study ID
- NCT05797168
- Run by
- AstraZeneca
- People needed
- 602
- Starts
- 2023-06-05
- Expected to finish
- 2028-08-04
- Last updated by the study team
- 2026-07-23
Who can join
Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Zhengzhou, China (enrolling)
- Research Site — Duarte, California, United States (enrolling)
- Research Site — Aurora, Colorado, United States (enrolling)
- Research Site — Xi'an, China (enrolling)
- Research Site — Boston, Massachusetts, United States (enrolling)
- Research Site — Detroit, Michigan, United States (enrolling)
- Research Site — Columbus, Ohio, United States (enrolling)
- Research Site — Portland, Oregon, United States (enrolling)
- Research Site — Providence, Rhode Island, United States (enrolling)
- Research Site — Irvine, California, United States (enrolling)
- Research Site — Houston, Texas, United States (enrolling)
- Research Site — Fairfax, Virginia, United States (enrolling)
- Research Site — Liverpool, Australia (enrolling)
- Research Site — Melbourne, Australia (enrolling)
- Research Site — Edmonton, Alberta, Canada (enrolling)
- Research Site — London, Ontario, Canada (enrolling)
- Research Site — Toronto, Ontario, Canada (enrolling)
- Research Site — Montreal, Quebec, Canada (enrolling)
- Research Site — Montreal, Quebec, Canada (enrolling)
- Research Site — Chengdu, China (enrolling)
- Research Site — Chongqing, China (enrolling)
- Research Site — Guangzhou, China (enrolling)
- Research Site — Guangzhou, China (enrolling)
- Research Site — Jinan, China (enrolling)
- Research Site — Berlin, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.